Application 219705
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | AXITINIB | AXITINIB | TABLET | 1MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INLYTA | AXITINIB | U.S. Pharmaceuticals | 8a903e31-936e-4ed7-8a59-59f32374f338 | 2026-03-12 | Warnings, Adverse reactions | AXITINIB |
| INLYTA | AXITINIB | Pfizer Laboratories Div Pfizer Inc | 84137882-e000-47da-bd5b-fa76ab3c76f9 | 2025-02-19 | Warnings, Adverse reactions | AXITINIB |